FAQ

Medical Internal Radiation Dose

Known as: MIRD 
The absorbed dose for a subject that results from ingestion of sources of radiation that reside throughout the subject over time. In particular a… (More)

Topic mentions per year

Topic mentions per year

1970-2017
0204019702017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature.
The internal dosimetry schema of the Medical Internal Radiation Dose (MIRD) Committee of the Society of Nuclear Medicine has… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumours with 90Y-DOTATOC and 177Lu-DOTATATE is promising. The… (More)
Is this relevant?
2008
2008
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.
Selective internal radiotherapy (SIRT) using Yttrium-90 labeled resin microspheres is increasingly used for the radioembolization… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
UNLABELLED Technical aspects and results of the dosimetric assessments of postoperative radioiodine ablation in the framework of… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2006
2006
Dosimetric techniques in 90Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations.
Therapy with 90Y-microspheres is emerging as a mainstream treatment modality in the management of patients with primary and… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.
UNLABELLED Nephrotoxicity is the major limiting factor during therapy with the radiolabeled somatostatin analog (90)Y-1,4,7,10… (More)
Is this relevant?
2004
2004
Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours
For the internal radiotherapy of neuroendocrine tumours, the somatostatin analogue DOTATOC labelled with 90Y is frequently used… (More)
  • table 1
  • figure 3
  • figure 1
  • figure 2
  • table 2
Is this relevant?
1999
1999
The MIRD perspective 1999. Medical Internal Radiation Dose Committee.
The MIRD schema is a general approach for medical internal radiation dosimetry. Although the schema has traditionally been used… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee.
The availability of quantitative three-dimensional in vivo data on radionuclide distributions within the body makes it possible… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours
A uniform distribution of yttrium-90 (90Y) microspheres throughout the entire liver has always been assumed for dose calculation… (More)
  • table 1
  • table 2
  • figure 2
Is this relevant?